Literature DB >> 23135319

Asymmetric dimethylarginine and carotid atherosclerosis in Type 2 diabetes mellitus.

W Xia1, Y Shao, Y Wang, X Wang, Y Chi.   

Abstract

BACKGROUND: Circulating asymmetric dimethylarginine (ADMA) concentration is elevated in patients with Type 2 diabetes mellitus (T2DM). AIM: To assess the relationship between plasma ADMA concentration and carotid atherosclerosis in patients with T2DM. SUBJECTS AND METHODS: A total of 72 newly diagnosed and untreated T2DM individuals and 72 healthy controls were studied. Carotid atherosclerosis was determined by ultrasonographically evaluated intima- media thickness (IMT) and plaque score. Plasma concentration of ADMA was measured by high-performance liquid chromatography.
RESULTS: Plasma ADMA, mean IMT, and plaque score were higher in diabetic patients compared with controls. Univariate and multivariate analyses demonstrated an independent association between ADMA and mean IMT in diabetic patients. On a multiple logistic regression analysis, ADMA was the sole predictor of carotid plaque formation (plaque score ≥1.1) (odds ratio 2.43, 95% confidence interval 1.19 to 4.94, p<0.05).
CONCLUSION: Our results suggest that increased levels of ADMA might be involved in the development of carotid atherosclerosis in T2DM.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23135319     DOI: 10.1007/BF03347101

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  32 in total

1.  Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage.

Authors:  T Nishikawa; D Edelstein; X L Du; S Yamagishi; T Matsumura; Y Kaneda; M A Yorek; D Beebe; P J Oates; H P Hammes; I Giardino; M Brownlee
Journal:  Nature       Date:  2000-04-13       Impact factor: 49.962

2.  Carotid intima-media thickness in relation to macrovascular disease in patients with type 2 diabetes mellitus.

Authors:  T Mudríková; E Szabová; I Tkác
Journal:  Wien Klin Wochenschr       Date:  2000-10-27       Impact factor: 1.704

3.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

4.  Asymmetric dimethylarginine as a risk factor for cardiovascular disease in Japanese patients with type 2 diabetes mellitus.

Authors:  Ippei Kanazawa; Shozo Yano; Yoshitomo Notsu; Toru Yamaguchi; Toru Nabika; Toshitsugu Sugimoto
Journal:  Clin Endocrinol (Oxf)       Date:  2011-04       Impact factor: 3.478

5.  Uncomplicated type 1 diabetes is associated with increased asymmetric dimethylarginine concentrations.

Authors:  Alev E Altinova; Metin Arslan; Aylin Sepici-Dincel; Mujde Akturk; Nilgun Altan; Fusun B Toruner
Journal:  J Clin Endocrinol Metab       Date:  2007-02-20       Impact factor: 5.958

6.  Plasma concentration of asymmetric dimethylarginine (ADMA) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy.

Authors:  Maria Lajer; Lise Tarnow; Anders Jorsal; Tom Teerlink; Hans-Henrik Parving; Peter Rossing
Journal:  Diabetes Care       Date:  2007-12-27       Impact factor: 19.112

7.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.

Authors:  K G Alberti; P Z Zimmet
Journal:  Diabet Med       Date:  1998-07       Impact factor: 4.359

8.  Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis: genetic and physiological evidence.

Authors:  Hayan Dayoub; Vinod Achan; Shanthi Adimoolam; Johannes Jacobi; Marcus C Stuehlinger; Bing-yin Wang; Philip S Tsao; M Kimoto; Patrick Vallance; Andrew J Patterson; John P Cooke
Journal:  Circulation       Date:  2003-11-24       Impact factor: 29.690

Review 9.  ADMA, cardiovascular disease and diabetes.

Authors:  Katarzyna Krzyzanowska; Friedrich Mittermayer; Michael Wolzt; Guntram Schernthaner
Journal:  Diabetes Res Clin Pract       Date:  2008-10-30       Impact factor: 5.602

10.  Asymmetric dimethylarginine produces vascular lesions in endothelial nitric oxide synthase-deficient mice: involvement of renin-angiotensin system and oxidative stress.

Authors:  Osamu Suda; Masato Tsutsui; Tsuyoshi Morishita; Hiromi Tasaki; Susumu Ueno; Sei Nakata; Takashi Tsujimoto; Yumiko Toyohira; Yoshiaki Hayashida; Yasuyuki Sasaguri; Yoichi Ueta; Yasuhide Nakashima; Nobuyuki Yanagihara
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-06-24       Impact factor: 8.311

View more
  7 in total

Review 1.  Asymmetric dimethylarginine, a biomarker of cardiovascular complications in diabetes mellitus.

Authors:  Hiroyuki Konya; Masayuki Miuchi; Kahori Satani; Satoshi Matsutani; Yuzo Yano; Taku Tsunoda; Takashi Ikawa; Toshihiro Matsuo; Fumihiro Ochi; Yoshiki Kusunoki; Masaru Tokuda; Tomoyuki Katsuno; Tomoya Hamaguchi; Jun-Ichiro Miyagawa; Mitsuyoshi Namba
Journal:  World J Exp Med       Date:  2015-05-20

2.  Asymmetric dimethylarginine is associated with high-sensitivity C-reactive protein and early carotid atherosclerosis in women with previous gestational diabetes mellitus.

Authors:  Wei Xia; Dajiang Li; Chunquan Zhang; Li Xu; Wenliang Xu; Yibing Shao
Journal:  Endocrine       Date:  2014-06-25       Impact factor: 3.633

3.  An assessment of correlation between serum asymmetric dimethylarginine and glycated haemoglobin in patients with type 2 diabetes mellitus.

Authors:  Asja Začiragić; Jasminko Huskić; Nedžad Mulabegović; Nesina Avdagić; Amina Valjevac; Sabaheta Hasić; Radivoj Jadrić
Journal:  Bosn J Basic Med Sci       Date:  2014-02       Impact factor: 3.363

4.  Supplementation with Phycocyanobilin, Citrulline, Taurine, and Supranutritional Doses of Folic Acid and Biotin-Potential for Preventing or Slowing the Progression of Diabetic Complications.

Authors:  Mark F McCarty
Journal:  Healthcare (Basel)       Date:  2017-03-14

5.  Metabolite and lipoprotein responses and prediction of weight gain during breast cancer treatment.

Authors:  Torfinn S Madssen; Inger Thune; Vidar G Flote; Steinar Lundgren; Gro F Bertheussen; Hanne Frydenberg; Erik Wist; Ellen Schlichting; Hartmut Schäfer; Hans E Fjøsne; Riyas Vettukattil; Jon Lømo; Tone F Bathen; Guro F Giskeødegård
Journal:  Br J Cancer       Date:  2018-11-07       Impact factor: 7.640

6.  Asymmetric dimethylarginine attenuates serum starvation-induced apoptosis via suppression of the Fas (APO-1/CD95)/JNK (SAPK) pathway.

Authors:  H Li; Y Zhou; A Zhao; Y Qiu; G Xie; Q Jiang; X Zheng; W Zhong; X Sun; Z Zhou; W Jia
Journal:  Cell Death Dis       Date:  2013-10-03       Impact factor: 8.469

7.  ADMA/SDMA in elderly subjects with asymptomatic carotid atherosclerosis: values and site-specific association.

Authors:  Graziano Riccioni; Luca Scotti; Nicolantonio D'Orazio; Sabina Gallina; Giuseppe Speziale; Lorenza Speranza; Tonino Bucciarelli
Journal:  Int J Mol Sci       Date:  2014-04-15       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.